Vaginal Atrophy following Long-Term Depot Medroxyprogesterone Acetate Use : A Case Report
Joint Authors
Badawy, Shawky Z. A.
Walker, Christie
Source
Case Reports in Obstetrics and Gynecology
Issue
Vol. 2013, Issue 2013 (31 Dec. 2013), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2013-03-06
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
Depot medroxyprogesterone acetate (DMPA) is a commonly used form of contraception, with noncontraceptive benefits for the user.
The mode of action is through the suppression of ovulation.
It leads to hypoestrogenism which causes dryness of the vagina and dyspareunia.
We present in this paper a patient that was very symptomatic with regard to vaginal atrophic changes determined by vaginal cytology.
This side effect may become increasingly more common as we see more long-term use of DMPA.
American Psychological Association (APA)
Walker, Christie& Badawy, Shawky Z. A.. 2013. Vaginal Atrophy following Long-Term Depot Medroxyprogesterone Acetate Use : A Case Report. Case Reports in Obstetrics and Gynecology،Vol. 2013, no. 2013, pp.1-3.
https://search.emarefa.net/detail/BIM-501915
Modern Language Association (MLA)
Walker, Christie& Badawy, Shawky Z. A.. Vaginal Atrophy following Long-Term Depot Medroxyprogesterone Acetate Use : A Case Report. Case Reports in Obstetrics and Gynecology No. 2013 (2013), pp.1-3.
https://search.emarefa.net/detail/BIM-501915
American Medical Association (AMA)
Walker, Christie& Badawy, Shawky Z. A.. Vaginal Atrophy following Long-Term Depot Medroxyprogesterone Acetate Use : A Case Report. Case Reports in Obstetrics and Gynecology. 2013. Vol. 2013, no. 2013, pp.1-3.
https://search.emarefa.net/detail/BIM-501915
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-501915
